BAT8006
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BAT8006, covering 2026-01-06 to 2026-01-07. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer [Phase 1, Phase 2]